(Q36349761)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16370964%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

title

The effect of antidepressants on glucose homeostasis and insulin sensitivity: synthesis and mechanisms (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16370964%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

0 references

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16370964%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Sidney H. Kennedy

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16370964%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

1

Roger S McIntyre

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16370964%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

author name string

Jakub Z Konarski

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16370964%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

language of work or name

English

0 references

publication date

1 January 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16370964%20AND%20SRC:MED&resulttype=core&format=json

Expert Opinion on Drug Safety

14 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16370964%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

volume

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16370964%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16370964%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

page(s)

157-168

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16370964%20AND%20SRC:MED&resulttype=core&format=json

Prevalence, Severity, and Unmet Need for Treatment of Mental Disorders in the World Health Organization World Mental Health Surveys

14 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.1.157

The relationship of depression to cardiovascular disease: epidemiology, biology, and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.1.157

Relationship of depression to diabetes types 1 and 2: epidemiology, biology, and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.1.157

Depression and bipolar disorder: relationships to impaired fatty acid and phospholipid metabolism and to diabetes, cardiovascular disease, immunological abnormalities, cancer, ageing and osteoporosis. Possible candidate genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.1.157

Depression and poor glycemic control: a meta-analytic review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.1.157

The serotonergic agent fluoxetine reduces neuropeptide Y levels and neuropeptide Y secretion in the hypothalamus of lean and obese rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.1.157

Plasma insulin levels are increased by sertraline in rats under oral glucose overload

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.1.157

Does fluoxetine administration influence insulin resistance in 90% pancreatectomized rats?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.1.157

Quality of life and metabolic status in mildly depressed women with type 2 diabetes treated with paroxetine: A single-blind randomised placebo controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.1.157

Effects of nortriptyline on depression and glycemic control in diabetes: results of a double-blind, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.1.157

Metabolic syndrome in bipolar disorder: findings from the Bipolar Disorder Center for Pennsylvanians

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.1.157

Comparing the effects of 8-week treatment with fluoxetine and imipramine on fasting blood glucose of patients with major depressive disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.1.157

Imipramine effect on hypothalamic-pituitary-adrenal axis response to hypoglycemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.1.157

Insulin resistance in patients with depression and its changes during the clinical course of depression: minimal model analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.1.157

Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.1.157

Venlafaxine extended release in the treatment of painful diabetic neuropathy: a double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.1.157

Duloxetine: pharmacoeconomic implications of an antidepressant that alleviates painful physical symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.1.157

Duloxetine vs. placebo in patients with painful diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.1.157

Insulin tolerance test in depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.1.157

Release of human neurophysin I during insulin-induced hypoglycemia in depressed patients is abolished after recovery with clomipramine treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.1.157

Bupropion SR vs. placebo for weight loss in obese patients with depressive symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.1.157

Loss of circadian rhythm in sleep-wakefulness cycle in the rat by suprachiasmatic nucleus lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.1.157

Additional evidence that the suprachiasmatic nucleus is the center for regulation of insulin secretion and glucose homeostasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.1.157

Treatment of depression in diabetes: impact on mood and medical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.1.157

Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.1.157

The cellular neurobiology of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.1.157

Mood disorders and allostatic load

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.1.157

Association of depression with medical illness: does cortisol play a role?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.1.157

Cytokine-induced sickness behaviour: a neuroimmune response to activation of innate immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.1.157

Interleukin-2 and interleukin-6 in schizophrenia and mania: Effects of neuroleptics and mood stabilizers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.1.157

Identifying the links between obesity, insulin resistance and beta-cell function: potential role of adipocyte-derived cytokines in the pathogenesis of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.1.157

Inflammatory status and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.1.157

Inflammatory mediators and islet beta-cell failure: a link between type 1 and type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.1.157

Effects of antidepressants on weight and on the plasma levels of leptin, TNF-alpha and soluble TNF receptors: A longitudinal study in patients treated with amitriptyline or paroxetine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.1.157

Contributions of 5-HT(2C) receptors to multiple actions of central serotonin systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.1.157

Neurobiology of an anorectic drug: fenfluramine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.1.157

Brain Serotonin Content: Physiological Regulation by Plasma Neutral Amino Acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.1.157

"Serotonin Depression"—A Biochemical Subgroup Within the Affective Disorders?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.1.157

Fenfluramine increases insulin action in patients with NIDDM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.1.157

Experimental diabetes in rats causes hippocampal dendritic and synaptic reorganization and increased glucocorticoid reactivity to stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.1.157

Localization and regulation of GLUTx1 glucose transporter in the hippocampus of streptozotocin diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.1.157

Ovarian steroids and the brain: implications for cognition and aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.1.157

Studies of hormone action in the hippocampal formation: possible relevance to depression and diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.1.157

Insulin and neurodegenerative disease: shared and specific mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.1.157